Skip to main content
. 2024 Feb 5;3:18. Originally published 2023 Apr 14. [Version 2] doi: 10.3310/nihropenres.13384.2

Figure 2.

Figure 2.

2a. Symptoms experienced by pwCF at least once a week by modulator status in 2022. 2b. Symptoms most affecting quality of life by modulator status in 2022 (modulator n= 76) non-modulator n=19) 2c. Top 3 symptoms reported in 2022 in the modulator group vs no modulator group with comparison to 2018 survey.